Zimulti
E874319
Zimulti is the brand name for rimonabant, a cannabinoid receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Zimulti canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T10610088 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Zimulti Context triple: [rimonabant, hasTradeName, Zimulti]
-
A.
ZUM
ZUM is the IATA airport code for Churchill Falls Airport in Newfoundland and Labrador, Canada.
-
B.
Züm
Züm is Brampton Transit's bus rapid transit service that provides faster, limited-stop connections across key corridors in Brampton and the surrounding region.
-
C.
ZIM
ZIM is the official International Cricket Council country code used to represent the Zimbabwe national cricket team in international cricket.
-
D.
Z.O.W.I.E.
Z.O.W.I.E. is a fictional secret intelligence agency from the 1967 spy parody film "In Like Flint," serving as a satirical counterpart to real-world espionage organizations.
-
E.
Big Z
Big Z is the longtime Cleveland Cavaliers center Zydrunas Ilgauskas, a two-time NBA All-Star known for his height, shooting touch, and resilience through foot injuries.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Zimulti Target entity description: Zimulti is the brand name for rimonabant, a cannabinoid receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
-
A.
ZUM
ZUM is the IATA airport code for Churchill Falls Airport in Newfoundland and Labrador, Canada.
-
B.
Züm
Züm is Brampton Transit's bus rapid transit service that provides faster, limited-stop connections across key corridors in Brampton and the surrounding region.
-
C.
ZIM
ZIM is the official International Cricket Council country code used to represent the Zimbabwe national cricket team in international cricket.
-
D.
Z.O.W.I.E.
Z.O.W.I.E. is a fictional secret intelligence agency from the 1967 spy parody film "In Like Flint," serving as a satirical counterpart to real-world espionage organizations.
-
E.
Big Z
Big Z is the longtime Cleveland Cavaliers center Zydrunas Ilgauskas, a two-time NBA All-Star known for his height, shooting touch, and resilience through foot injuries.
- F. None of above. chosen
Statements (40)
| Predicate | Object |
|---|---|
| instanceOf |
anti-obesity drug
ⓘ
brand name drug ⓘ |
| ATCCode | A08AX01 ⓘ |
| belongsTo | Sanofi obesity drug portfolio ⓘ |
| blackBoxConcern | suicidality risk ⓘ |
| chemicalName | rimonabant ⓘ |
| contraindication |
major depression
ⓘ
ongoing psychiatric disorders ⓘ |
| developedBy |
Sanofi-Aventis
ⓘ
linked to:
Sanofi
|
| developmentStatus | development terminated for commercial use ⓘ |
| drugClass | cannabinoid receptor antagonist ⓘ |
| firstApprovalRegion | European Union ⓘ |
| firstApprovalYear | 2006 ⓘ |
| hasActiveIngredient | rimonabant ⓘ |
| hasAdverseEffect |
anxiety
ⓘ
depression ⓘ insomnia ⓘ mood disorders ⓘ nausea ⓘ suicidal ideation ⓘ vomiting ⓘ |
| indication |
obesity
ⓘ
smoking cessation (investigational) ⓘ weight management ⓘ |
| legalStatus | discontinued ⓘ |
| mechanismOfAction | selective CB1 receptor antagonism ⓘ |
| pharmacologicalClass | anorectic agent ⓘ |
| reasonForWithdrawal |
increased risk of depression
ⓘ
increased risk of suicidal behavior ⓘ psychiatric side effects ⓘ |
| receptorBinding | CB1 receptor antagonist ⓘ |
| regulatoryStatus |
not approved by FDA in United States
ⓘ
withdrawn from market in European Union ⓘ |
| routeOfAdministration | oral ⓘ |
| targets | CB1 receptor ⓘ |
| therapeuticArea | metabolic disorders ⓘ |
| therapeuticEffect |
reduction of appetite
ⓘ
weight loss ⓘ |
| tradeNameOf | rimonabant ⓘ |
| withdrawalYear | 2008 ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Zimulti Description of subject: Zimulti is the brand name for rimonabant, a cannabinoid receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.